SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '6b3e'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID		 Hit
Macromolecule		 Res.
Matches		 Interface HETATM RMSD Dali
Z-score		 Seq.
Identity (%)		 View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1IEP_B_STIB202_2
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		4 / 7 VAL A 787
MET A 816
ARG A 858
LEU A 866
 None
None
TPO  A 893 ( 3.0A)
CJM  A1102 (-4.4A)
 0.72A 1iepB-6b3eA:
23.0		 1iepB-6b3eA:
15.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1OPJ_A_STIA3_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		6 / 12 VAL A 741
ALA A 754
GLU A 774
VAL A 787
LEU A 866
ALA A 876
 None
CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.49A 1opjA-6b3eA:
22.8		 1opjA-6b3eA:
15.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1T3R_A_017A1200_2
(PROTEASE RETROPEPSIN)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 11 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 0.93A 1t3rB-6b3eA:
undetectable		 1t3rB-6b3eA:
20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2EUF_B_LQQB401_1
(CELL DIVISION
PROTEIN KINASE 6)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		10 / 12 ILE A 733
VAL A 741
LYS A 756
VAL A 787
PHE A 813
ASP A 819
ASN A 864
LEU A 866
ALA A 876
ASP A 877
 CJM  A1102 (-3.4A)
None
None
None
CJM  A1102 ( 4.4A)
CJM  A1102 (-4.1A)
MG  A1101 ( 4.4A)
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
MG  A1101 (-2.5A)
 0.76A 2eufB-6b3eA:
34.4		 2eufB-6b3eA:
16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2FUM_A_MIXA539_1
(PROBABLE
SERINE/THREONINE-PRO
TEIN KINASE PKNB)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 12 GLY A 734
VAL A 741
ALA A 754
ASP A 859
LYS A 861
ASN A 864
ASP A 877
 CJM  A1102 (-3.4A)
None
CJM  A1102 (-3.1A)
MG  A1101 (-3.7A)
None
MG  A1101 ( 4.4A)
MG  A1101 (-2.5A)
 0.83A 2fumA-6b3eA:
25.7		 2fumA-6b3eA:
13.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2IVU_A_ZD6A3015_0
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE RECEPTOR RET
PRECURSOR)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		8 / 12 GLY A 734
VAL A 741
LYS A 756
GLU A 774
LEU A 778
LEU A 811
TYR A 815
ASP A 877
 CJM  A1102 (-3.4A)
None
None
None
None
None
CJM  A1102 (-4.1A)
MG  A1101 (-2.5A)
 0.87A 2ivuA-6b3eA:
25.7		 2ivuA-6b3eA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2PL0_A_STIA200_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE LCK)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 12 VAL A 741
ALA A 754
GLU A 774
VAL A 787
TYR A 815
LEU A 866
ALA A 876
 None
CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.67A 2pl0A-6b3eA:
22.8		 2pl0A-6b3eA:
17.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Q6F_C_010C6_0
(INFECTIOUS
BRONCHITIS VIRUS
(IBV) MAIN PROTEASE
N-[(5-METHYLISOXAZOL
-3-YL)CARBONYL]ALANY
L-L-VALYL-N~1~-((1R,
2Z)-4-(BENZYLOXY)-4-
OXO-1-{[(3R)-2-OXOPY
RROLIDIN-3-YL]METHYL
}BUT-2-ENYL)-L-LEUCI
NAMIDE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		3 / 3 ASN A 854
LEU A 856
HIS A 851
 None
 0.81A 2q6fB-6b3eA:
undetectable		 2q6fB-6b3eA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2V0M_B_KLNB1498_1
(CYTOCHROME P450 3A4)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 9 SER A 921
LEU A 856
ILE A 897
GLY A 846
LEU A 875
 None
 1.10A 2v0mB-6b3eA:
undetectable		 2v0mB-6b3eA:
9.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2WGJ_A_VGHA2346_1
(HEPATOCYTE GROWTH
FACTOR RECEPTOR)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 12 GLY A 734
VAL A 741
ALA A 754
TYR A 815
MET A 816
ALA A 876
ASP A 877
 CJM  A1102 (-3.4A)
None
CJM  A1102 (-3.1A)
CJM  A1102 (-4.1A)
None
CJM  A1102 (-3.6A)
MG  A1101 (-2.5A)
 0.71A 2wgjA-6b3eA:
23.8		 2wgjA-6b3eA:
19.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7J_A_B49A1294_1
(PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		6 / 12 ILE A 733
VAL A 741
ALA A 754
PHE A 813
MET A 816
LEU A 866
 CJM  A1102 (-3.4A)
None
CJM  A1102 (-3.1A)
CJM  A1102 ( 4.4A)
None
CJM  A1102 (-4.4A)
 0.52A 2y7jA-6b3eA:
29.0		 2y7jA-6b3eA:
11.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7J_B_B49B1294_1
(PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		6 / 10 ILE A 733
VAL A 741
ALA A 754
PHE A 813
MET A 816
LEU A 866
 CJM  A1102 (-3.4A)
None
CJM  A1102 (-3.1A)
CJM  A1102 ( 4.4A)
None
CJM  A1102 (-4.4A)
 0.54A 2y7jB-6b3eA:
29.2		 2y7jB-6b3eA:
11.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7J_C_B49C1294_1
(PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		6 / 10 ILE A 733
VAL A 741
ALA A 754
PHE A 813
MET A 816
LEU A 866
 CJM  A1102 (-3.4A)
None
CJM  A1102 (-3.1A)
CJM  A1102 ( 4.4A)
None
CJM  A1102 (-4.4A)
 0.56A 2y7jC-6b3eA:
22.2		 2y7jC-6b3eA:
11.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2Y7J_D_B49D1294_1
(PHOSPHORYLASE B
KINASE GAMMA
CATALYTIC CHAIN,
TESTIS/LIVER ISOFORM)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		6 / 10 ILE A 733
VAL A 741
ALA A 754
PHE A 813
MET A 816
LEU A 866
 CJM  A1102 (-3.4A)
None
CJM  A1102 (-3.1A)
CJM  A1102 ( 4.4A)
None
CJM  A1102 (-4.4A)
 0.54A 2y7jD-6b3eA:
29.0		 2y7jD-6b3eA:
11.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKV_A_478A200_2
(PROTEASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 9 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 0.94A 3ekvB-6b3eA:
undetectable		 3ekvB-6b3eA:
21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G5D_B_1N1B1_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		8 / 12 VAL A 741
ALA A 754
LYS A 756
GLU A 774
VAL A 787
TYR A 815
LEU A 866
ALA A 876
 None
CJM  A1102 (-3.1A)
None
None
None
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.85A 3g5dB-6b3eA:
24.5		 3g5dB-6b3eA:
15.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GVU_A_STIA1001_1
(TYROSINE-PROTEIN
KINASE ABL2)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		6 / 12 VAL A 741
ALA A 754
GLU A 774
VAL A 787
LEU A 866
ALA A 876
 None
CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.55A 3gvuA-6b3eA:
23.4		 3gvuA-6b3eA:
13.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_A_0LIA1_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 12 ALA A 754
GLU A 774
VAL A 787
LEU A 866
ALA A 876
 CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.54A 3ik3A-6b3eA:
23.4		 3ik3A-6b3eA:
16.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_A_0LIA1_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 12 ALA A 754
VAL A 787
HIS A 857
LEU A 866
ALA A 876
 CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.39A 3ik3A-6b3eA:
23.4		 3ik3A-6b3eA:
16.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3IK3_B_0LIB2_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE ABL1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		6 / 12 ALA A 754
GLU A 774
VAL A 787
HIS A 857
LEU A 866
ALA A 876
 CJM  A1102 (-3.1A)
None
None
None
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.56A 3ik3B-6b3eA:
23.3		 3ik3B-6b3eA:
16.30
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LFA_A_1N1A361_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 14)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 8 ALA A 754
LYS A 756
GLU A 774
LEU A 811
MET A 816
 CJM  A1102 (-3.1A)
None
None
None
None
 0.51A 3lfaA-6b3eA:
26.9		 3lfaA-6b3eA:
12.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LXK_A_MI1A1125_1
(TYROSINE-PROTEIN
KINASE JAK3)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		8 / 12 GLY A 734
VAL A 741
ALA A 754
LYS A 756
VAL A 787
TYR A 815
ALA A 876
ASP A 877
 CJM  A1102 (-3.4A)
None
CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.1A)
CJM  A1102 (-3.6A)
MG  A1101 (-2.5A)
 1.03A 3lxkA-6b3eA:
25.1		 3lxkA-6b3eA:
16.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3LXK_A_MI1A1125_1
(TYROSINE-PROTEIN
KINASE JAK3)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		8 / 12 GLY A 734
VAL A 741
ALA A 754
VAL A 787
TYR A 815
LEU A 866
ALA A 876
ASP A 877
 CJM  A1102 (-3.4A)
None
CJM  A1102 (-3.1A)
None
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
MG  A1101 (-2.5A)
 1.02A 3lxkA-6b3eA:
25.1		 3lxkA-6b3eA:
16.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MIY_A_B49A1_1
(TYROSINE-PROTEIN
KINASE ITK/TSK)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 11 ILE A 733
ALA A 754
LYS A 756
VAL A 787
PHE A 813
MET A 816
LEU A 866
 CJM  A1102 (-3.4A)
CJM  A1102 (-3.1A)
None
None
CJM  A1102 ( 4.4A)
None
CJM  A1102 (-4.4A)
 0.82A 3miyA-6b3eA:
23.9		 3miyA-6b3eA:
16.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3MIY_B_B49B2_1
(TYROSINE-PROTEIN
KINASE ITK/TSK)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		6 / 9 ILE A 733
ALA A 754
LYS A 756
PHE A 813
MET A 816
LEU A 866
 CJM  A1102 (-3.4A)
CJM  A1102 (-3.1A)
None
CJM  A1102 ( 4.4A)
None
CJM  A1102 (-4.4A)
 0.64A 3miyB-6b3eA:
23.7		 3miyB-6b3eA:
16.02
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NU3_B_478B401_1
(PROTEASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 12 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 0.99A 3nu3A-6b3eA:
undetectable		 3nu3A-6b3eA:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NU4_B_478B401_1
(PROTEASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 9 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 0.96A 3nu4A-6b3eA:
undetectable		 3nu4A-6b3eA:
21.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NUJ_B_478B401_1
(PROTEASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 10 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 1.00A 3nujA-6b3eA:
undetectable		 3nujA-6b3eA:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NUO_B_478B478_1
(PROTEASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 9 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 0.97A 3nuoA-6b3eA:
undetectable		 3nuoA-6b3eA:
22.55
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OEZ_A_STIA601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 12 VAL A 741
ALA A 754
GLU A 774
VAL A 787
TYR A 815
LEU A 866
ALA A 876
 None
CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.66A 3oezA-6b3eA:
23.0		 3oezA-6b3eA:
15.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OEZ_B_STIB601_1
(PROTO-ONCOGENE
TYROSINE-PROTEIN
KINASE SRC)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 12 VAL A 741
ALA A 754
LYS A 756
GLU A 774
TYR A 815
LEU A 866
ALA A 876
 None
CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.75A 3oezB-6b3eA:
23.2		 3oezB-6b3eA:
15.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3OY4_B_017B200_1
(HIV-1 PROTEASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 11 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 0.95A 3oy4A-6b3eA:
undetectable		 3oy4A-6b3eA:
20.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PS9_A_SAMA670_0
(TRNA
5-METHYLAMINOMETHYL-
2-THIOURIDINE
BIOSYNTHESIS
BIFUNCTIONAL PROTEIN
MNMC)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 12 PHE A1019
GLY A 923
PHE A 930
ILE A 925
MET A 840
 None
 1.31A 3ps9A-6b3eA:
undetectable		 3ps9A-6b3eA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3PYY_B_STIB4_1
(V-ABL ABELSON MURINE
LEUKEMIA VIRAL
ONCOGENE HOMOLOG 1
ISOFORM B VARIANT)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		6 / 12 VAL A 741
ALA A 754
GLU A 774
VAL A 787
LEU A 866
ALA A 876
 None
CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.55A 3pyyB-6b3eA:
22.9		 3pyyB-6b3eA:
12.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3QT0_A_486A4_2
(PEROXISOME
PROLIFERATOR-ACTIVAT
ED RECEPTOR GAMMA)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		4 / 4 LYS A 861
GLN A 937
ILE A 948
LEU A 906
 None
 1.21A 3qt0A-6b3eA:
undetectable		 3qt0A-6b3eA:
14.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3R0L_D_ACTD127_0
(PHOSPHOLIPASE A2 CB)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		4 / 5 ILE A 860
GLY A 846
CYH A 850
HIS A 851
 None
 1.07A 3r0lD-6b3eA:
undetectable		 3r0lD-6b3eA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3RGF_A_BAXA465_1
(CYCLIN-DEPENDENT
KINASE 8)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		8 / 12 VAL A 741
ALA A 754
GLU A 774
LEU A 778
PHE A 813
TYR A 815
HIS A 857
ALA A 876
 None
CJM  A1102 (-3.1A)
None
None
CJM  A1102 ( 4.4A)
CJM  A1102 (-4.1A)
None
CJM  A1102 (-3.6A)
 0.60A 3rgfA-6b3eA:
10.9		 3rgfA-6b3eA:
13.71
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3S43_A_478A401_1
(PROTEASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 9 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 0.93A 3s43A-6b3eA:
undetectable		 3s43A-6b3eA:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TI1_A_B49A299_1
(CYCLIN-DEPENDENT
KINASE 2)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 9 ILE A 733
ALA A 754
PHE A 813
ASP A 819
LEU A 866
 CJM  A1102 (-3.4A)
CJM  A1102 (-3.1A)
CJM  A1102 ( 4.4A)
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
 0.41A 3ti1A-6b3eA:
32.2		 3ti1A-6b3eA:
21.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TI1_A_B49A299_1
(CYCLIN-DEPENDENT
KINASE 2)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 9 ILE A 733
ALA A 754
VAL A 787
ASP A 819
LEU A 866
 CJM  A1102 (-3.4A)
CJM  A1102 (-3.1A)
None
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
 0.78A 3ti1A-6b3eA:
32.2		 3ti1A-6b3eA:
21.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3TI1_A_B49A299_1
(CYCLIN-DEPENDENT
KINASE 2)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 9 ILE A 733
VAL A 787
ASP A 819
LEU A 866
ASP A 877
 CJM  A1102 (-3.4A)
None
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
MG  A1101 (-2.5A)
 0.73A 3ti1A-6b3eA:
32.2		 3ti1A-6b3eA:
21.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3WZD_A_LEVA1201_2
(VASCULAR ENDOTHELIAL
GROWTH FACTOR
RECEPTOR 2)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		4 / 5 ILE A 777
VAL A 787
LEU A 866
ASP A 877
 None
None
CJM  A1102 (-4.4A)
MG  A1101 (-2.5A)
 0.91A 3wzdA-6b3eA:
22.5		 3wzdA-6b3eA:
15.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZOS_A_0LIA1000_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 12 ALA A 754
LYS A 756
GLU A 774
HIS A 857
ARG A 858
LEU A 866
ALA A 876
 CJM  A1102 (-3.1A)
None
None
None
TPO  A 893 ( 3.0A)
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.76A 3zosA-6b3eA:
22.2		 3zosA-6b3eA:
15.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ZOS_B_0LIB1000_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 12 ALA A 754
LYS A 756
GLU A 774
HIS A 857
ARG A 858
LEU A 866
ALA A 876
 CJM  A1102 (-3.1A)
None
None
None
TPO  A 893 ( 3.0A)
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.74A 3zosB-6b3eA:
22.3		 3zosB-6b3eA:
15.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ANQ_A_VGHA9000_1
(ALK TYROSINE KINASE
RECEPTOR)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		6 / 9 VAL A 741
ALA A 754
MET A 816
LEU A 866
ALA A 876
ASP A 877
 None
CJM  A1102 (-3.1A)
None
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
MG  A1101 (-2.5A)
 0.77A 4anqA-6b3eA:
22.7		 4anqA-6b3eA:
11.73
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4AQL_A_TXCA1452_2
(GUANINE DEAMINASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		4 / 5 HIS A 851
LEU A1001
LEU A 926
ASP A 998
 None
 0.97A 4aqlA-6b3eA:
undetectable		 4aqlA-6b3eA:
10.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BKJ_A_STIA1000_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 12 VAL A 741
ALA A 754
GLU A 774
ILE A 777
TYR A 815
LEU A 866
ALA A 876
 None
CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.64A 4bkjA-6b3eA:
22.5		 4bkjA-6b3eA:
15.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BKJ_A_STIA1000_2
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		4 / 4 LYS A 756
LEU A 781
MET A 816
ARG A 858
 None
None
None
TPO  A 893 ( 3.0A)
 1.14A 4bkjA-6b3eA:
22.5		 4bkjA-6b3eA:
15.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BKJ_B_STIB1000_1
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		6 / 12 VAL A 741
ALA A 754
GLU A 774
ILE A 777
LEU A 866
ALA A 876
 None
CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.62A 4bkjB-6b3eA:
22.6		 4bkjB-6b3eA:
15.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BKJ_B_STIB1000_2
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		4 / 5 LEU A 781
TYR A 815
MET A 816
ARG A 773
 None
CJM  A1102 (-4.1A)
None
None
 1.31A 4bkjB-6b3eA:
22.6		 4bkjB-6b3eA:
15.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BKJ_B_STIB1000_2
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		4 / 5 LEU A 781
TYR A 815
MET A 816
ARG A 858
 None
CJM  A1102 (-4.1A)
None
TPO  A 893 ( 3.0A)
 0.88A 4bkjB-6b3eA:
22.6		 4bkjB-6b3eA:
15.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4BKJ_B_STIB1000_2
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		4 / 5 LYS A 756
LEU A 781
MET A 816
ARG A 858
 None
None
None
TPO  A 893 ( 3.0A)
 1.12A 4bkjB-6b3eA:
22.6		 4bkjB-6b3eA:
15.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C8B_A_0LIA1000_1
(RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 2)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 12 ALA A 754
LYS A 756
GLU A 774
LEU A 778
HIS A 857
LEU A 866
ALA A 876
 CJM  A1102 (-3.1A)
None
None
None
None
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.74A 4c8bA-6b3eA:
24.2		 4c8bA-6b3eA:
12.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4C8B_B_0LIB1000_1
(RECEPTOR-INTERACTING
SERINE/THREONINE-PRO
TEIN KINASE 2)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 12 ALA A 754
LYS A 756
GLU A 774
LEU A 778
HIS A 857
LEU A 866
ALA A 876
 CJM  A1102 (-3.1A)
None
None
None
None
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.81A 4c8bB-6b3eA:
24.0		 4c8bB-6b3eA:
12.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4CSV_A_STIA1265_1
(SRC-ABL TYROSINE
KINASE ANCESTOR)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		8 / 12 VAL A 741
ALA A 754
GLU A 774
ILE A 777
VAL A 787
TYR A 815
LEU A 866
ALA A 876
 None
CJM  A1102 (-3.1A)
None
None
None
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.68A 4csvA-6b3eA:
23.8		 4csvA-6b3eA:
14.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4JEC_B_478B401_2
(HIV-1 PROTEASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 12 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 0.95A 4jecB-6b3eA:
undetectable		 4jecB-6b3eA:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4KAN_B_ADNB401_2
(PROBABLE SUGAR
KINASE PROTEIN)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		3 / 3 SER A 954
TYR A 978
PRO A 904
 None
 0.99A 4kanB-6b3eA:
undetectable		 4kanB-6b3eA:
14.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJT_B_017B101_1
(PROTEASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 11 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 0.95A 4njtA-6b3eA:
undetectable		 4njtA-6b3eA:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4NJT_D_017D101_1
(PROTEASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 11 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 0.93A 4njtC-6b3eA:
undetectable		 4njtC-6b3eA:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OGR_A_ADNA401_1
(CYCLIN-DEPENDENT
KINASE 9)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 8 ILE A 733
VAL A 741
ALA A 754
ASP A 819
ASN A 864
LEU A 866
ASP A 877
 CJM  A1102 (-3.4A)
None
CJM  A1102 (-3.1A)
CJM  A1102 (-4.1A)
MG  A1101 ( 4.4A)
CJM  A1102 (-4.4A)
MG  A1101 (-2.5A)
 0.41A 4ogrA-6b3eA:
40.3		 4ogrA-6b3eA:
15.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OGR_I_ADNI401_1
(CYCLIN-DEPENDENT
KINASE 9)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 9 ILE A 733
VAL A 741
ALA A 754
ASP A 819
ASN A 864
LEU A 866
ASP A 877
 CJM  A1102 (-3.4A)
None
CJM  A1102 (-3.1A)
CJM  A1102 (-4.1A)
MG  A1101 ( 4.4A)
CJM  A1102 (-4.4A)
MG  A1101 (-2.5A)
 0.48A 4ogrI-6b3eA:
40.0		 4ogrI-6b3eA:
15.88
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 10 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 0.91A 4q1wB-6b3eA:
undetectable		 4q1wB-6b3eA:
22.77
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q1Y_A_017A106_2
(ASPARTYL PROTEASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 12 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 0.96A 4q1yB-6b3eA:
undetectable		 4q1yB-6b3eA:
21.78
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QMN_A_DB8A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 24)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 12 ILE A 733
ALA A 754
GLU A 774
TYR A 815
LEU A 866
ALA A 876
ASP A 877
 CJM  A1102 (-3.4A)
CJM  A1102 (-3.1A)
None
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
MG  A1101 (-2.5A)
 0.78A 4qmnA-6b3eA:
29.6		 4qmnA-6b3eA:
13.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QMN_A_DB8A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 24)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		6 / 12 ILE A 733
ALA A 754
LYS A 756
GLU A 774
TYR A 815
LEU A 866
 CJM  A1102 (-3.4A)
CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
 0.81A 4qmnA-6b3eA:
29.6		 4qmnA-6b3eA:
13.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QMS_A_1N1A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 24)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 11 ILE A 733
ALA A 754
LYS A 756
GLU A 774
TYR A 815
LEU A 866
ASP A 877
 CJM  A1102 (-3.4A)
CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
MG  A1101 (-2.5A)
 0.90A 4qmsA-6b3eA:
29.7		 4qmsA-6b3eA:
13.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4QMZ_A_B49A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 24)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		6 / 12 ILE A 733
GLY A 734
VAL A 741
ALA A 754
TYR A 815
LEU A 866
 CJM  A1102 (-3.4A)
CJM  A1102 (-3.4A)
None
CJM  A1102 (-3.1A)
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
 0.67A 4qmzA-6b3eA:
30.0		 4qmzA-6b3eA:
13.59
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RVJ_B_478B101_1
(HIV-1 PROTEASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 11 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 0.96A 4rvjA-6b3eA:
undetectable		 4rvjA-6b3eA:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4RVJ_D_478D101_1
(HIV-1 PROTEASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 11 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 0.96A 4rvjC-6b3eA:
undetectable		 4rvjC-6b3eA:
19.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TWP_A_AXIA601_1
(TYROSINE-PROTEIN
KINASE ABL1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		8 / 12 VAL A 741
ALA A 754
LYS A 756
MET A 816
ASN A 864
LEU A 866
ALA A 876
ASP A 877
 None
CJM  A1102 (-3.1A)
None
None
MG  A1101 ( 4.4A)
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
MG  A1101 (-2.5A)
 0.52A 4twpA-6b3eA:
25.5		 4twpA-6b3eA:
15.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4TYJ_A_0LIA801_1
(FIBROBLAST GROWTH
FACTOR RECEPTOR 4)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 12 ALA A 754
GLU A 774
HIS A 857
LEU A 866
ALA A 876
 CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.61A 4tyjA-6b3eA:
22.6		 4tyjA-6b3eA:
12.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4V04_A_0LIA1772_1
(FIBROBLAST GROWTH
FACTOR RECEPTOR 1
(FMS-RELATED
TYROSINE KINASE 2,
PFEIFFER SYNDROME),
ISOFORM CRA_B)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		6 / 12 VAL A 741
ALA A 754
GLU A 774
CYH A 850
HIS A 857
ALA A 876
 None
CJM  A1102 (-3.1A)
None
None
None
CJM  A1102 (-3.6A)
 1.17A 4v04A-6b3eA:
22.1		 4v04A-6b3eA:
16.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4WNW_A_RTZA602_1
(CYTOCHROME P450 2D6)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 12 PHE A 839
LEU A 843
GLY A 822
LEU A 823
VAL A 829
 None
 1.11A 4wnwA-6b3eA:
undetectable		 4wnwA-6b3eA:
12.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XV2_A_P06A801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 12 VAL A 741
ALA A 754
LYS A 756
ASP A 877
PHE A 878
 None
CJM  A1102 (-3.1A)
None
MG  A1101 (-2.5A)
None
 0.59A 4xv2A-6b3eA:
23.7		 4xv2A-6b3eA:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4XV2_B_P06B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 12 ALA A 754
LYS A 756
LEU A 778
ASP A 877
PHE A 878
 CJM  A1102 (-3.1A)
None
None
MG  A1101 (-2.5A)
None
 0.69A 4xv2B-6b3eA:
24.1		 4xv2B-6b3eA:
16.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CSW_A_P06A801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 12 VAL A 741
ALA A 754
LYS A 756
LEU A 778
PHE A 878
 None
CJM  A1102 (-3.1A)
None
None
None
 0.66A 5cswA-6b3eA:
23.6		 5cswA-6b3eA:
17.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5CSW_B_P06B801_1
(SERINE/THREONINE-PRO
TEIN KINASE B-RAF)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 12 VAL A 741
ALA A 754
LYS A 756
LEU A 778
PHE A 878
 None
CJM  A1102 (-3.1A)
None
None
None
 0.62A 5cswB-6b3eA:
23.4		 5cswB-6b3eA:
17.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5DNV_A_BEZA304_0
(SHKAI2IB)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		4 / 5 HIS A 857
ILE A 917
ILE A 897
TYR A 913
 None
None
None
TPO  A 893 ( 4.4A)
 1.06A 5dnvA-6b3eA:
undetectable		 5dnvA-6b3eA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5I9Y_A_1N1A1001_1
(EPHRIN TYPE-A
RECEPTOR 2)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		6 / 12 ILE A 733
ALA A 754
LYS A 756
GLU A 774
TYR A 815
LEU A 866
 CJM  A1102 (-3.4A)
CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
 0.70A 5i9yA-6b3eA:
23.4		 5i9yA-6b3eA:
16.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5KR0_A_478A101_1
(PROTEASE E35D-APV)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 9 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 1.03A 5kr0A-6b3eA:
undetectable		 5kr0A-6b3eA:
21.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L2I_A_LQQA900_1
(CYCLIN-DEPENDENT
KINASE 6)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		9 / 12 GLY A 734
VAL A 741
ALA A 754
VAL A 787
PHE A 813
ASP A 819
LEU A 866
ALA A 876
ASP A 877
 CJM  A1102 (-3.4A)
None
CJM  A1102 (-3.1A)
None
CJM  A1102 ( 4.4A)
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
MG  A1101 (-2.5A)
 0.89A 5l2iA-6b3eA:
13.1		 5l2iA-6b3eA:
16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L2I_A_LQQA900_1
(CYCLIN-DEPENDENT
KINASE 6)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 12 ILE A 733
GLY A 734
VAL A 741
ALA A 754
PHE A 813
ASP A 819
LEU A 866
 CJM  A1102 (-3.4A)
CJM  A1102 (-3.4A)
None
CJM  A1102 (-3.1A)
CJM  A1102 ( 4.4A)
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
 0.74A 5l2iA-6b3eA:
13.1		 5l2iA-6b3eA:
16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L2T_A_6ZZA900_1
(CYCLIN-DEPENDENT
KINASE 6)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 12 GLY A 734
VAL A 787
PHE A 813
ASP A 819
LEU A 866
ALA A 876
ASP A 877
 CJM  A1102 (-3.4A)
None
CJM  A1102 ( 4.4A)
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
MG  A1101 (-2.5A)
 0.96A 5l2tA-6b3eA:
13.4		 5l2tA-6b3eA:
16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L2T_A_6ZZA900_1
(CYCLIN-DEPENDENT
KINASE 6)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		8 / 12 ILE A 733
GLY A 734
ALA A 754
VAL A 787
PHE A 813
ASP A 819
LEU A 866
ALA A 876
 CJM  A1102 (-3.4A)
CJM  A1102 (-3.4A)
CJM  A1102 (-3.1A)
None
CJM  A1102 ( 4.4A)
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 1.03A 5l2tA-6b3eA:
13.4		 5l2tA-6b3eA:
16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5L2T_A_6ZZA900_1
(CYCLIN-DEPENDENT
KINASE 6)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		8 / 12 ILE A 733
VAL A 741
ALA A 754
VAL A 787
PHE A 813
ASP A 819
LEU A 866
ALA A 876
 CJM  A1102 (-3.4A)
None
CJM  A1102 (-3.1A)
None
CJM  A1102 ( 4.4A)
CJM  A1102 (-4.1A)
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.91A 5l2tA-6b3eA:
13.4		 5l2tA-6b3eA:
16.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LJE_A_RTLA201_0
(RETINOL-BINDING
PROTEIN 1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 12 LEU A 843
LEU A 875
LEU A1001
TYR A 901
LEU A 997
 None
 1.10A 5ljeA-6b3eA:
undetectable		 5ljeA-6b3eA:
undetectable
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5LW1_B_ADNB401_1
(MITOGEN-ACTIVATED
PROTEIN KINASE 8)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 9 ILE A 733
GLY A 734
VAL A 741
ALA A 754
MET A 816
 CJM  A1102 (-3.4A)
CJM  A1102 (-3.4A)
None
CJM  A1102 (-3.1A)
None
 0.67A 5lw1B-6b3eA:
28.2		 5lw1B-6b3eA:
23.33
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5M8R_A_MMSA511_1
(5,6-DIHYDROXYINDOLE-
2-CARBOXYLIC ACID
OXIDASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		4 / 7 HIS A 818
LEU A 820
VAL A 829
SER A 826
 None
 1.04A 5m8rA-6b3eA:
undetectable		 5m8rA-6b3eA:
10.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MO4_A_NILA601_2
(TYROSINE-PROTEIN
KINASE ABL1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 12 ALA A 754
VAL A 787
HIS A 857
LEU A 866
ALA A 876
 CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.50A 5mo4A-6b3eA:
20.1		 5mo4A-6b3eA:
10.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MVS_A_ADNA401_1
(HISTONE-LYSINE
N-METHYLTRANSFERASE,
H3 LYSINE-79
SPECIFIC)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		4 / 7 GLY A 871
ALA A1029
PHE A 839
ASN A 869
 None
 0.98A 5mvsA-6b3eA:
undetectable		 5mvsA-6b3eA:
15.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5OWR_A_1N1A401_1
(SERINE/THREONINE-PRO
TEIN KINASE 10)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		4 / 8 ALA A 754
GLU A 774
LEU A 866
ASP A 877
 CJM  A1102 (-3.1A)
None
CJM  A1102 (-4.4A)
MG  A1101 (-2.5A)
 0.41A 5owrA-6b3eA:
16.8		 5owrA-6b3eA:
15.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YF9_B_NIOB401_1
(CASEIN KINASE II
SUBUNIT ALPHA')		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		4 / 7 VAL A 741
LYS A 756
PHE A 813
ASP A 877
 None
None
CJM  A1102 ( 4.4A)
MG  A1101 (-2.5A)
 0.64A 5yf9B-6b3eA:
16.3		 5yf9B-6b3eA:
22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5YWM_X_NIOX403_0
(CASEIN KINASE II
SUBUNIT ALPHA')		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		4 / 7 VAL A 741
LYS A 756
PHE A 813
ASP A 877
 None
None
CJM  A1102 ( 4.4A)
MG  A1101 (-2.5A)
 0.46A 5ywmX-6b3eA:
32.1		 5ywmX-6b3eA:
22.35
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6BSD_A_1N1A901_0
(EPITHELIAL DISCOIDIN
DOMAIN-CONTAINING
RECEPTOR 1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		7 / 12 VAL A 741
ALA A 754
LYS A 756
GLU A 774
TYR A 815
MET A 816
LEU A 866
 None
CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.1A)
None
CJM  A1102 (-4.4A)
 0.50A 6bsdA-6b3eA:
22.3		 6bsdA-6b3eA:
15.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DGX_A_017A101_1
(PROTEASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 12 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 0.95A 6dgxB-6b3eA:
undetectable		 6dgxB-6b3eA:
22.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6DH3_A_017A101_1
(PROTEASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		5 / 12 ALA A 993
ASP A 995
GLY A 923
ILE A 925
ILE A 989
 None
 0.95A 6dh3B-6b3eA:
undetectable		 6dh3B-6b3eA:
22.89
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6HD4_A_STIA604_0
(TYROSINE-PROTEIN
KINASE ABL1)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		6 / 12 VAL A 741
ALA A 754
GLU A 774
VAL A 787
LEU A 866
ALA A 876
 None
CJM  A1102 (-3.1A)
None
None
CJM  A1102 (-4.4A)
CJM  A1102 (-3.6A)
 0.56A 6hd4A-6b3eA:
22.6		 6hd4A-6b3eA:
32.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
6MKE_C_FK5C201_0
(PEPTIDYLPROLYL
ISOMERASE)		 6b3e CYCLIN-DEPENDENT
KINASE 12
(Homo
sapiens) 		4 / 4 ASP A 998
ILE A 989
PRO A 990
LEU A 994
 None
 1.46A 6mkeB-6b3eA:
undetectable		 6mkeB-6b3eA:
22.35